Last reviewed · How we verify

NCT05509101

Improving Myoelectric Prosthetic and Orthotic Limb Control

Status unknown NA Last updated 25 September 2023
What this trial tests

NA trial testing commercially available control algorithm in Hemiparesis in 45 participants. Status unknown.

Timeline
1 March 2017
Primary endpoint
31 August 2025
31 August 2025

Quick facts

Lead sponsorUniversity of Utah
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeother
Enrollment45
Start date1 March 2017
Primary completion31 August 2025
Estimated completion31 August 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Utah

Who can join

Adults 18 to 70, any sex, with Hemiparesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to improve control of myoelectrically-controlled advanced orthotic devices (an exoskeleton device that use the body's muscle signals to drive movements of a robotic brace) by using advanced predictive decode algorithms, and the use of high count (\> 8) surface electromyographic (sEMG) electrodes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hemiparesis

Currently open trials in the same condition.

Other University of Utah trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05509101.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing